- €12.49m
- €6.71m
- €15.95m
Brief: Otofarma H1 Net Loss €0.5 Mln
Brief: Otofarma Unit Signs Partnership With Free Optik Group
Brief: Otofarma FY Pro-Forma Net Loss EUR 1.5 Mln
Brief: Otofarma FY Adj EBITDA EUR 2.4 Mln
Brief: Otofarma Says Closing Completed For New Facility In Milan
Brief: Otofarma Appoints Gennaro Bartolomucci As Chief Executive Officer
Brief: Otofarma Appoints Nicola Mottola As CFO
Brief: Otofarma Buys Production Plant In Milan For EUR 1.5 Mln
Brief: Otofarma H1 Adj. EBITDA EUR 0.8 Mln
Brief: Otofarma Fully Exercises Greenshoe Option Amid Capital Increase For Total Of 190,500 Shares
Italy - Factors to watch on Aug. 6